The Return Trends At Elevance Health (NYSE:ELV) Look Promising
The Return Trends At Elevance Health (NYSE:ELV) Look Promising
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want to see a proven return on capital employed (ROCE) that is increasing, and secondly, an expanding base of capital employed. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. So when we looked at Elevance Health (NYSE:ELV) and its trend of ROCE, we really liked what we saw.
你知道有一些財務指標可以提供潛在大宗股的線索嗎?首先,我們希望看到持續增長的資本回報率(ROCE),其次,是不斷擴大的資本投入基礎。這向我們表明它是一個複利機器,能夠持續將收益再投資於業務中併產生更高的回報。因此,當我們查看Elevance Health(紐交所:ELV)及其ROCE的趨勢時,我們非常喜歡我們所看到的。
Return On Capital Employed (ROCE): What Is It?
資本回報率(ROCE):它是什麼?
For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. The formula for this calculation on Elevance Health is:
對於那些不確定ROCE是什麼的人,它衡量的是公司從其投入的資本中可以產生的稅前利潤的數量。對於Elevance Health,這一計算的公式爲:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
資本利用率 = 利息和稅前利潤(EBIT) ÷ (總資產 - 流動負債)
0.14 = US$11b ÷ (US$117b - US$42b) (Based on the trailing twelve months to September 2024).
0.14 = 110億美金 ÷ (1170億美金 - 42億美金)(基於截至2024年9月的過去12個月數據)。
Therefore, Elevance Health has an ROCE of 14%. In absolute terms, that's a satisfactory return, but compared to the Healthcare industry average of 10% it's much better.
因此,Elevance Health的ROCE爲14%。在絕對值上,這是一個令人滿意的回報,但與醫療行業平均水平的10%相比,表現要好得多。
Above you can see how the current ROCE for Elevance Health compares to its prior returns on capital, but there's only so much you can tell from the past. If you're interested, you can view the analysts predictions in our free analyst report for Elevance Health .
上面可以看到Elevance Health當前的資本回報率如何與其過去的資本回報相比,但從過去能了解的信息有限。如果你有興趣,可以查看我們關於Elevance Health的免費分析師報告中的預測。
So How Is Elevance Health's ROCE Trending?
那麼Elevance Health的資本回報率趨勢如何?
Investors would be pleased with what's happening at Elevance Health. Over the last five years, returns on capital employed have risen substantially to 14%. The company is effectively making more money per dollar of capital used, and it's worth noting that the amount of capital has increased too, by 37%. The increasing returns on a growing amount of capital is common amongst multi-baggers and that's why we're impressed.
投資者會對Elevance Health的情況感到滿意。在過去五年中,所用資本的回報率顯著上升至14%。公司每投入一美元的資本所賺取的利潤有效提高,而且值得注意的是,資本的總量也增加了37%。資本回報率的提升和資本總量的增長在多倍增長的公司中很常見,這就是我們印象深刻的原因。
What We Can Learn From Elevance Health's ROCE
我們可以從Elevance Health的資本回報率中學到什麼
All in all, it's terrific to see that Elevance Health is reaping the rewards from prior investments and is growing its capital base. Investors may not be impressed by the favorable underlying trends yet because over the last five years the stock has only returned 34% to shareholders. Given that, we'd look further into this stock in case it has more traits that could make it multiply in the long term.
總的來說,看到Elevance Health從之前的投資中獲得回報並且其資本基礎正在擴大是令人欣慰的。投資者可能對過去五年來股票僅給股東帶來34%的回報仍未感到滿意。因此,我們會進一步研究這支股票,看看是否還有其他特徵可以使其在長期內翻倍。
On a separate note, we've found 2 warning signs for Elevance Health you'll probably want to know about.
另一方面,我們發現Elevance Health有2個警告信號,你可能想了解一下。
While Elevance Health may not currently earn the highest returns, we've compiled a list of companies that currently earn more than 25% return on equity. Check out this free list here.
儘管Elevance Health目前可能並未獲得最高的回報,但我們彙總了一份目前獲得超過25%股本回報的公司名單。請在這裏查看這份免費名單。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall St的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St在提到的任何股票中均沒有持倉。
譯文內容由第三人軟體翻譯。
評論(0)
請選擇舉報原因